definiens: means the enrollment of the first patient or subject in such Clinical Trial . In the eventthat Dance does not meet one or more of the foregoing milestones with respect to the Drug Product and such failureis due in whole or in part to ( i ) an event of force majeure, ( ii ) any defects in the Device, ( iii ) any delays with respect tothe design, development, testing, manufacture or supply of the Device meeting Specifications and ProductRequirements, ( iv ) any acts or omissions of [COMPANY] or its employees, agents or contractors, ( v ) any acts oromissions of any Regulatory Authority, ( vi ) any new Laws, ( vi ) adverse results of a technical or clinical ( by way ofexample but not limitation, unacceptable product properties from a safety, toxicity or efficacy standpoint, then theabove milestones will be extended as mutually agreed by the Parties taking into account such circumstances . In theevent that Dance does not meet one or more of the foregoing milestones and/or Dance fails to use CommerciallyReasonable Efforts to make commercial sales and this failure is not remedied within six months of notice to thateffect being delivered to Dance by [COMPANY], solely or mainly due to issues unrelated to any of the circumstancesdescribed in the preceding subsections ( i ) through 15(vi ), then in addition to the extinguishment of [COMPANY] ’s obligations not to compete with Dance pursuant toSection 6.5 ( Non - Compete in Territory ), Dance ’s License shall automatically convert to a non - exclusive license fora period of twelve ( 12 ) months from the date of the missed milestone . If at the end of such twelve ( 12 ) month period, Dance still has not met the applicable milestone, then Dance ’s License shall be automatically revoked . If, however, during such twelve ( 12 ) months, Dance does meet the missed milestone and [COMPANY] has not licensed the rightsunder the License to a third party, then such License shall re - convert to an exclusive license in favor of Dance